HRMY
Harmony Biosciences Holdings, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-24
Figures on this page computed 2026-11-08 12:32 UTC
Last close
34.42USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-24
12.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-24
53.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-11-04
18.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
40.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
0.19Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-11-04
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth40.3%72 of 100, above its sector
- Returns on capital53.6%91 of 100, above its sector
- Margins77.2%90 of 100, above its sector
- Price12.0x54 of 100, above its sector
- Safety0.1975 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Six questions
lens 5 of 9Six questions
5 yes of 6 answered- 1Does it earn money?yes
net margin, read above 0.
- 2Can it pay what it owes?yes
interest coverage, read above 3.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?yes
fcf margin, read above 0.
- 5Is it issuing shares?no
share count change yoy, read below 1.
- 6Is it priced under twenty times earnings?yes
pe ratio, read below 20.
5 of 6 questions answered yes; 0 could not be answered.
5 of 6 questions answered yes; 0 could not be answered.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-24
Does it earn money?18.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
Can it pay what it owes?14.2x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
Is it bigger than five years ago?40.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
Does the profit turn into cash?40.1%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
Is it issuing shares?1.2%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD
Is it priced under twenty times earnings?12.0x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001104659-26-018859
- Reported in
- USD